The results indicate that PON1 activity may be resilient to the hyperglycemic, hypertriglyceridemic, and pro-inflammatory milieu that is present in subjects with T2D; further, PON1 activity may only be significantly reduced in subjects with long-standing T2D. This evidence concerns the gene PON1 and type 2 diabetes mellitus.